Jacqueline Mock (Jaqueline Mock)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Venues

Pharmaceutics

Proceedings of the National Academy of Sciences of the United States of America

Scientific reports

Nature communications

Swiss Federal Institute of Technology in Zurich

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Swiss Federal Institute of Technology in Zurich May 01 2018

Switzerland

Doctoral Student :: Pharmaceutical Sciences

Publications

Cesare Di Nitto, Ettore Gilardoni, Jacqueline Mock, Lisa Nadal, Tobias Weiss, Michael Weller, Frauke Seehusen, Chiara Libbra, Emanuele Puca, Dario Neri, Roberto De Luca
An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties. Pharmaceutics 15 (2) (2023)
Cesare Di Nitto, Ettore Gilardoni, Jacqueline Mock, Lisa Nadal, Tobias Weiss, Michael Weller, Frauke Seehusen, Chiara Libbra, Emanuele Puca, Dario Neri, Roberto De Luca
An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties. Pharmaceutics 15 (2) (2023)
Cesare Di Nitto, Ettore Gilardoni, Jacqueline Mock, Lisa Nadal, Tobias Weiss, Michael Weller, Frauke Seehusen, Chiara Libbra, Emanuele Puca, Dario Neri, Roberto De Luca
An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties. Pharmaceutics 15 (2) (2023)
Cesare Di Nitto, Ettore Gilardoni, Jacqueline Mock, Lisa Nadal, Tobias Weiss, Michael Weller, Frauke Seehusen, Chiara Libbra, Emanuele Puca, Dario Neri, Roberto De Luca
An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties. Pharmaceutics 15 (2) (2023)
Abdullah Elsayed, Christian Pellegrino, Louis Plüss, Frederik Peissert, Ramon Benz, Franziska Ulrich, Gudrun Thorhallsdottir, Sheila Dakhel Plaza, Alessandra Villa, Jacqueline Mock, Emanuele Puca, Roberto De Luca, Markus Gabriel Manz, Cornelia Halin, Dario Neri
Generation of a novel fully human non-superagonistic anti-CD28 antibody with efficient and safe T-cell co-stimulation properties. mAbs 15 (1) (2023)
Riccardo Corbellari, Marco Stringhini, Jacqueline Mock, Tiziano Ongaro, Alessandra Villa, Dario Neri, Roberto De Luca
A Novel Antibody-IL15 Fusion Protein Selectively Localizes to Tumors, Synergizes with TNF-based Immunocytokine, and Inhibits Metastasis. Molecular cancer therapeutics 20 (5) (2021)
Sheila Dakhel, Christian Lizak, Mattia Matasci, Jacqueline Mock, Alessandra Villa, Dario Neri, Samuele Cazzamalli
An Attenuated Targeted-TNF Localizes to Tumors In Vivo and Regains Activity at the Site of Disease. International journal of molecular sciences 22 (18) (2021)
Jacqueline Mock, Marco Stringhini, Alessandra Villa, Michael Weller, Tobias Weiss, Dario Neri
An engineered 4-1BBL fusion protein with "activity on demand". Proceedings of the National Academy of Sciences of the United States of America 117 (50) (2020)
Jacqueline Mock, Christian Pellegrino, Dario Neri
A universal reporter cell line for bioactivity evaluation of engineered cytokine products. Scientific reports 10 (1) (2020)
Hanne L P Tytgat, Chia-Wei Lin, Mikail D Levasseur, Markus B Tomek, Christoph Rutschmann, Jacqueline Mock, Nora Liebscher, Naohiro Terasaka, Yusuke Azuma, Michael Wetter, Martin F Bachmann, Donald Hilvert, Markus Aebi, Timothy G Keys
Cytoplasmic glycoengineering enables biosynthesis of nanoscale glycoprotein assemblies. Nature communications 10 (1) (2019)

Jacqueline Mock.css-eqlu8i{font-size:small;padding-left:4px;} (Jaqueline Mock)

Publication Activity (10 Years)

Top Topics

Top Venues

Jacqueline Mock (Jaqueline Mock)